2653 monitored
← Actor desksRead-only · existing recordsClassic graph view ↗

Sentinels / Actor desk

Shreeram Inamdar

person · Registry status: unverified

3adc08d0-945a-5ee1-b545-ed3320e74b18

Evidence, not intent.

Public-source event mentions and stored signals. Adjacency does not establish causation, coordination, or an actor's position.

No claim of complete coverage or live monitoring.

Observation window

UTC dates, inclusive · maximum 90 days. Applies to events and anomalies only.

Recent observations / timeline

The source record

23 distinct events shown, newest first. Headlines may be generated summaries; inspect the source before repeating a claim.

  1. Poor, Young, Disposable: How Bishnoi Gang Recruits

    Recorded role: co mention · TAX_FNCACT_GANGSTER

    Open source ↗
  2. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_FNCACT_SENIOR_VICE_PRESIDENT

    Open source ↗
  3. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · SCIENCE

    Open source ↗
  4. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · LEADER

    Open source ↗
  5. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · WB_678_DIGITAL_GOVERNMENT

    Open source ↗
  6. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · SCIENCE

    Open source ↗
  7. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · EPU_CATS_HEALTHCARE

    Open source ↗
  8. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_FNCACT_CANDIDATES

    Open source ↗
  9. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · GENERAL_GOVERNMENT

    Open source ↗
  10. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_FNCACT_INVESTOR

    Open source ↗
  11. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_MILITARY_TITLE_OFFICER

    Open source ↗
  12. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · EPU_CATS_HEALTHCARE

    Open source ↗
  13. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · EPU_CATS_HEALTHCARE

    Open source ↗
  14. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_DISEASE_CANCER

    Open source ↗
  15. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_FNCACT_VICE_PRESIDENT

    Open source ↗
  16. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · TAX_FNCACT_INVESTOR

    Open source ↗
  17. Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · EPU_POLICY_LAW

    Open source ↗
  18. Zymeworks Inc.: Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026

    Recorded role: co mention · PROTEST

    Open source ↗
  19. Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

    Recorded role: co mention · EPU_POLICY_BUDGET

    Open source ↗
  20. Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3

    Recorded role: co mention · EPU_POLICY_BUDGET

    Open source ↗
  21. Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

    Recorded role: co mention · MEDICAL

    Open source ↗
  22. Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

    Recorded role: co mention · SOC_INNOVATION

    Open source ↗
  23. Zymeworks Announces Participation in Upcoming Investor Conferences and Date of Third Quarter 2026 Financial Results

    Recorded role: co mention · WB_1614_NUTRITIONAL_PROGRAMS

    Open source ↗

Signals to inspect

Anomalies

Latest 3 in the selected window (up to 10). Detector output, not verified conclusions.

high · volume spike

Volume spike: 6 events in window (6.0x baseline of 1.0 expected)

critical · coordination signal

Coordination signal: co-actor 25d4133c-ae3f-58ef-bbbb-49e352aacab7 appeared in 5 of 6 window events (83%)

high · volume spike

Volume spike: 8 events in window (8.0x baseline of 1.0 expected)

Narrative context

Unresolved threads

Latest 20 at most, across all dates. Stored narratives require human review.

No unresolved threads recorded.

Stored connections

Relationships

Up to 50 records ordered by evidence count, across all dates. Co-mentions indicate association in source material, not affiliation or coordination.

Ask this desk

Desk analyst

Read-only questions about Shreeram Inamdar's stored record. Answers cite only records retrieved for that turn; a citation chip opens the existing inspection view. Absence of matches is not evidence of inactivity.

Operator sign-in is required. Sign in

Identity is the existing actor registry record. Entity resolution and source coverage may be incomplete.